Tele-monitoring for infectious diseases: a remote system for assessing patient parameters and specimen analysis
Ended Definitive Contract Awarded Last action
- Contract number
- HHSN272201600030C
- Awardee
-
Glucosentient Inc. UEI Z1GKW7XKS2P1
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $224,751
Award facts
- Opportunity
-
- PHS20161 Solicitation number
- A Low Cost Integrated Method for Isolation of M. Tuberculosis DNA from Raw Sputum Award Notice · Posted Jul 2, 2015
- Contract value 100% obligated
- $224,751.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 5 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Champaign, IL 61820, USA
- Legislative mandates
-
- Davis-Bacon Act FAR subpart 22.4
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Original award | $224,751 |
About this award
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $224,751 firm-fixed-price contract to Glucosentient Inc., a small business, for the development of a "TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS." The contract, which has an ultimate completion date of August 29, 2017, was set aside for small businesses. Glucosentient, a for-profit organization specializing in point-of-care diagnostic technologies, has previously received federal grants from NIAID and the National Institute of Dental and Craniofacial Research to develop diagnostic solutions for tuberculosis, hepatitis C, and oral cancer.
Quick answers
Who was awarded contract HHSN272201600030C?
HHSN272201600030C was awarded to Glucosentient Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 30, 2016.
How much is contract HHSN272201600030C worth?
The government has obligated $224,751 on HHSN272201600030C.
Was contract HHSN272201600030C competed?
The extent of competition for HHSN272201600030C was full and open competition after exclusion of sources. The government received 5 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award